Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with COPD and/or Asthma: A Population Study.

Kendzerska T, Aaron SD, To T, Licskai C, Stanbrook M, Vozoris N, Hogan ME, Tan WC, Bourbeau J, Gershon AS; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2019 Jul 12. doi: 10.1513/AnnalsATS.201902-126OC. [Epub ahead of print]

PMID:
31298938
2.

Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta-analysis.

Johnston A, Smith C, Zheng C, Aaron SD, Kelly SE, Skidmore B, Wells GA.

Clin Exp Allergy. 2019 Jul 11. doi: 10.1111/cea.13457. [Epub ahead of print]

PMID:
31295369
3.

Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study.

Shorofsky M, Bourbeau J, Kimoff J, Jen R, Malhotra A, Ayas N, Tan WC, Aaron SD, Sin DD, Road J, Chapman KR, O'Donnell DE, Maltais F, Hernandez P, Walker BL, Marciniuk D, Kaminska M; Canadian Respiratory Research Network and the CanCOLD Collaborative Research group.

Chest. 2019 May 28. pii: S0012-3692(19)31121-3. doi: 10.1016/j.chest.2019.04.132. [Epub ahead of print]

PMID:
31150638
4.

Development and External Validation of 1- and 2- year Mortality Prediction Models in Cystic Fibrosis.

Stanojevic S, Sykes J, Stephenson AL, Aaron SD, Whitmore GA.

Eur Respir J. 2019 May 16. pii: 1900224. doi: 10.1183/13993003.00224-2019. [Epub ahead of print]

PMID:
31097523
5.

"Placebo Effects" in Clinical Trials Evaluating Patients with Uncontrolled Persistent Asthma.

Luc F, Prieur E, Whitmore GA, Gibson PG, Vandemheen KL, Aaron SD.

Ann Am Thorac Soc. 2019 May 7. doi: 10.1513/AnnalsATS.201901-071OC. [Epub ahead of print]

PMID:
31063408
6.

Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study.

Paine NJ, Bacon SL, Bourbeau J, Tan WC, Lavoie KL; CanCOLD Study Investigators, Aaron SD, Chapman KR, FitzGerald JM, Hernandez P, Marciniuk DD, Maltais F, O'Donnell DE, Sin D, Walker BL; Canadian Respiratory Research Network and teh CanCOLD Collaborative Research Group.

Respir Med. 2019 Jan;146:1-9. doi: 10.1016/j.rmed.2018.11.006. Epub 2018 Nov 15.

7.

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Brinkhurst J, Wells GA.

CMAJ. 2018 Dec 3;190(48):E1406-E1413. doi: 10.1503/cmaj.180232.

8.

Reply to Bergl: Diagnostic Failures in Asthma.

Aaron SD.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):543. doi: 10.1164/rccm.201810-2004LE. No abstract available.

PMID:
30376357
9.

Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).

Kendzerska T, Leung RS, Aaron SD, Ayas N, Sandoz JS, Gershon AS.

Ann Am Thorac Soc. 2019 Jan;16(1):71-81. doi: 10.1513/AnnalsATS.201802-136OC.

PMID:
30372124
10.

Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study.

Ma KA, Kahn SR, Akaberi A, Dennie C, Rush C, Granton JT, Anderson D, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Hernandez P, Aaron SD, Pena E, Abikhzer G, Hirsch AM; ELOPE Study group.

Res Pract Thromb Haemost. 2018 Jun 17;2(4):670-677. doi: 10.1002/rth2.12123. eCollection 2018 Oct.

11.

Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma.

Villa-Roel C, Borgundvaag B, Majumdar SR, Emond M, Campbell S, Sivilotti M, Abu-Laban RB, Stiell IG, Aaron SD, Senthilselvan A, Rowe BH; AIR Investigators.

J Asthma. 2018 Oct 12:1-10. doi: 10.1080/02770903.2018.1508472. [Epub ahead of print]

PMID:
30311821
12.

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement.

Kim V, Aaron SD.

Eur Respir J. 2018 Nov 15;52(5). pii: 1801261. doi: 10.1183/13993003.01261-2018. Print 2018 Nov.

PMID:
30237306
13.

Breathlessness catastrophizing relates to poorer quality of life in adults with cystic fibrosis.

Maras D, Balfour L, Tasca GA, Gaudet E, Aaron SD, Cameron WD, Pakhale S.

J Cyst Fibros. 2019 Jan;18(1):150-157. doi: 10.1016/j.jcf.2018.08.008. Epub 2018 Sep 7.

PMID:
30197031
14.

Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD.

Jin M, Lee EC, Ra SW, Fishbane N, Tam S, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Aaron SD, Reed RM, Man SFP, Leung JM, Sin DD.

Chest. 2018 Aug;154(2):266-273. doi: 10.1016/j.chest.2018.05.022. Epub 2018 Jul 12.

PMID:
30017346
15.

Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease.

Diab N, Gershon AS, Sin DD, Tan WC, Bourbeau J, Boulet LP, Aaron SD.

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1130-1139. doi: 10.1164/rccm.201804-0621CI.

PMID:
29979608
16.

End-of-Life Strategies among Patients with Advanced Chronic Obstructive Pulmonary Disease.

Gershon AS, Maclagan LC, Luo J, To T, Kendzerska T, Stanbrook MB, Bourbeau J, Etches J, Aaron SD.

Am J Respir Crit Care Med. 2018 Dec 1;198(11):1389-1396. doi: 10.1164/rccm.201803-0592OC.

PMID:
29889548
17.

Between-Visit Variability in FEV1 as a Diagnostic Test for Asthma in Adults.

Dean BW, Birnie EE, Whitmore GA, Vandemheen KL, Boulet LP, FitzGerald JM, Ainslie M, Gupta S, Lemiere C, Field SK, McIvor RA, Hernandez P, Mayers I, Aaron SD; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2018 Sep;15(9):1039-1046. doi: 10.1513/AnnalsATS.201803-211OC.

PMID:
29877740
18.

Underdiagnosis and Overdiagnosis of Asthma.

Aaron SD, Boulet LP, Reddel HK, Gershon AS.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1012-1020. doi: 10.1164/rccm.201804-0682CI.

PMID:
29756989
19.

Exploring below the Tip of the Iceberg: The Prognostic Impact of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Primary Care.

Aaron SD.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):415-416. doi: 10.1164/rccm.201802-0372ED. No abstract available.

PMID:
29529380
20.

Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.

Leitao Filho FS, Ra SW, Mattman A, Schellenberg RS, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Paul Man SF, Aaron SD, Reed RM, Sin DD; Canadian Respiratory Research Network (CRRN).

Respir Res. 2018 Feb 14;19(1):30. doi: 10.1186/s12931-018-0733-z.

21.

Health Services Burden of Undiagnosed and Overdiagnosed COPD.

Gershon AS, Thiruchelvam D, Chapman KR, Aaron SD, Stanbrook MB, Bourbeau J, Tan W, To T; Canadian Respiratory Research Network.

Chest. 2018 Jun;153(6):1336-1346. doi: 10.1016/j.chest.2018.01.038. Epub 2018 Feb 6.

PMID:
29425675
22.

Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease.

Vozoris NT, Wang X, Austin PC, O'Donnell DE, Aaron SD, To TM, Gershon AS.

Br J Clin Pharmacol. 2018 Mar;84(3):579-589. doi: 10.1111/bcp.13465. Epub 2017 Dec 6.

24.

Mucolytics for COPD: negotiating a slippery slope towards proof of efficacy.

Aaron SD.

Eur Respir J. 2017 Oct 12;50(4). pii: 1701465. doi: 10.1183/13993003.01465-2017. Print 2017 Oct. No abstract available.

25.

Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study.

Gershon AS, Macdonald EM, Luo J, Austin PC, Gupta S, Sivjee K, Upshur R, Aaron SD.

Fam Pract. 2017 Nov 16;34(6):708-716. doi: 10.1093/fampra/cmx058.

PMID:
28985364
26.

CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise.

Washko GR, Coxson HO, O'Donnell DE, Aaron SD.

Lancet Respir Med. 2017 Nov;5(11):903-908. doi: 10.1016/S2213-2600(17)30345-4. Epub 2017 Sep 28.

PMID:
28965820
27.

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

de Sousa Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD, Benedetti A, Chapman KR, Walker B, Fitzgerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Bourbeau J; CanCOLD Collaborative Research Group and The Canadian Respiratory Research Network.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701154. doi: 10.1183/13993003.01154-2017. Print 2017 Sep. No abstract available.

28.

A first step to STOP cystic fibrosis exacerbations.

Burgel PR, Reid DW, Aaron SD.

J Cyst Fibros. 2017 Sep;16(5):529-531. doi: 10.1016/j.jcf.2017.08.006. No abstract available.

PMID:
28865768
29.

Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE. No abstract available.

PMID:
28858570
30.

Reaching for the Holy Grail of Chronic Obstructive Pulmonary Disease Outcomes. Can Medications Modify Lung Function Decline?

Aaron SD.

Am J Respir Crit Care Med. 2018 Jan 1;197(1):2-4. doi: 10.1164/rccm.201708-1549ED. No abstract available.

PMID:
28806533
31.

Increased prevalence of colonic adenomas in patients with cystic fibrosis.

Hegagi M, Aaron SD, James P, Goel R, Chatterjee A.

J Cyst Fibros. 2017 Nov;16(6):759-762. doi: 10.1016/j.jcf.2017.07.009. Epub 2017 Jul 23.

PMID:
28743561
32.

The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis.

Chin M, Aaron SD, Bell SC.

Presse Med. 2017 Jun;46(6 Pt 2):e139-e164. doi: 10.1016/j.lpm.2016.11.030. Epub 2017 May 31. Review.

PMID:
28576636
33.

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.

Ra SW, Sze MA, Lee EC, Tam S, Oh Y, Fishbane N, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Aaron SD, Reed RM, Man SFP, Sin DD; Canadian Respiratory Research Network.

Respir Res. 2017 May 30;18(1):109. doi: 10.1186/s12931-017-0594-x.

34.

Reassessment of an Asthma Diagnosis-Reply.

Aaron SD.

JAMA. 2017 May 2;317(17):1802. doi: 10.1001/jama.2017.3507. No abstract available.

PMID:
28464138
35.

Blood Pressure Medications to Prevent Emphysema? Take These Pills with a Grain of Salt.

Aaron SD.

Ann Am Thorac Soc. 2017 May;14(5):619-620. doi: 10.1513/AnnalsATS.201701-023ED. No abstract available.

PMID:
28459624
36.

Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease.

Leitao Filho FS, Won Ra S, Mattman A, Schellenberg RS, Fishbane N, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Man SFP, Aaron SD, Reed RM, Sin DD.

J Allergy Clin Immunol. 2017 Oct;140(4):1164-1167.e6. doi: 10.1016/j.jaci.2017.01.046. Epub 2017 Apr 27. No abstract available.

PMID:
28456620
37.

Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study.

Kahn SR, Akaberi A, Granton JT, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Hernandez P, Aaron SD, Hirsch AM.

Am J Med. 2017 Aug;130(8):990.e9-990.e21. doi: 10.1016/j.amjmed.2017.03.033. Epub 2017 Apr 8.

PMID:
28400247
38.

Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing.

Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD; Canadian Respiratory Research Network.

CMAJ. 2017 Apr 10;189(14):E530-E538. doi: 10.1503/cmaj.151420. Epub 2016 Nov 14.

39.

N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.

Ma K, Kahn SR, Hirsch AM, Akaberi A, Anderson DR, Wells PS, Rodger M, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Hernandez P, Aaron SD, Granton JT.

Thromb Res. 2017 May;153:47-49. doi: 10.1016/j.thromres.2017.03.005. Epub 2017 Mar 8. No abstract available.

PMID:
28319825
40.

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality.

Kendzerska T, Sadatsafavi M, Aaron SD, To TM, Lougheed MD, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network.

PLoS One. 2017 Mar 16;12(3):e0173830. doi: 10.1371/journal.pone.0173830. eCollection 2017.

41.

Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction.

Aaron SD, Tan WC, Bourbeau J, Sin DD, Loves RH, MacNeil J, Whitmore GA; Canadian Respiratory Research Network.

Am J Respir Crit Care Med. 2017 Aug 1;196(3):306-314. doi: 10.1164/rccm.201612-2531OC.

PMID:
28267373
42.

A clinical tool to calculate post-transplant survival using pre-transplant clinical characteristics in adults with cystic fibrosis.

Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Chaparro C, Aaron SD, Whitmore GA, Stanojevic S.

Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12950. Epub 2017 Apr 23.

PMID:
28267234
43.

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Bourbeau J, Aaron SD, Barnes NC, Davis KJ, Lacasse Y, Nadeau G.

Respir Med. 2017 Feb;123:94-97. doi: 10.1016/j.rmed.2016.12.015. Epub 2016 Dec 23. Review.

44.

Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma.

Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, Mulpuru S, Alvarez GG, Pakhale S, Mallick R, Boulet LP; Canadian Respiratory Research Network.

JAMA. 2017 Jan 17;317(3):269-279. doi: 10.1001/jama.2016.19627.

PMID:
28114551
45.

Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP.

Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Wells GA.

Acad Emerg Med. 2017 Mar;24(3):316-327. doi: 10.1111/acem.13141.

46.

Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study.

Kahn SR, Hirsch AM, Akaberi A, Hernandez P, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Geerts WH, Aaron SD, Granton JT.

Chest. 2017 May;151(5):1058-1068. doi: 10.1016/j.chest.2016.11.030. Epub 2016 Dec 6.

PMID:
27932051
47.

Changes in the Cystic Fibrosis Airway Microbiome after Lung Transplant: The More Things Change, the More They Stay the Same.

Aaron SD.

Ann Am Thorac Soc. 2016 Dec;13(12):2109-2110. No abstract available.

PMID:
27925782
48.

Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Tan WC, Hague CJ, Leipsic J, Bourbeau J, Zheng L, Li PZ, Sin DD, Coxson HO, Kirby M, Hogg JC, Raju R, Road J, O'Donnell DE, Maltais F, Hernandez P, Cowie R, Chapman KR, Marciniuk DD, FitzGerald JM, Aaron SD; Canadian Respiratory Research Network and the CanCOLD Collaborative Research group.

PLoS One. 2016 Nov 18;11(11):e0166745. doi: 10.1371/journal.pone.0166745. eCollection 2016.

49.

Influence of country-level differences on COPD prevalence.

Aaron SD, Gershon AS, Gao Y, Yang J, Whitmore GA.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2305-2313. eCollection 2016.

50.

Addressing the misdiagnosis of asthma in adults: where does it go wrong?

MacNeil J, Loves RH, Aaron SD.

Expert Rev Respir Med. 2016 Nov;10(11):1187-1198. doi: 10.1080/17476348.2016.1242415. Epub 2016 Oct 8.

PMID:
27677224

Supplemental Content

Loading ...
Support Center